Kendall Law Group, founded by a former federal judge, is investigating the proposed acquisition of QuadraMed Corp. (NASDAQ: QDHC) by Francisco Partners. The firm’s investigation concerns whether the consideration to be paid to shareholders in this transaction is unfair and substantially below the fair or inherent value of the company. Also, the investigation will focus on whether the Board of Directors of QuadraMed may have breached their fiduciary duties by disregarding the shareholders' interests in not adequately shopping the Company before entering into the transaction.

On December 8, 2009, the companies announced that Francisco Partners will acquire QuadraMed in an all-cash transaction valued at $126 million. According to the agreement, shareholders will receive $8.50 per share for QDHC common stock and $13.7097 per share of Series A Cumulative Mandatory Convertible Preferred Stock. This represents a 32.6% premium over the $6.41 closing price of QuadraMed common stock just prior to the announcement, and approximately 7% over the 52-week high.

If you are a current holder of QDHC and would like additional information concerning this proposed transaction, including your rights, contact Hamilton Lindley at 877-744-3728 or by email at hlindley@kendalllawgroup.com. Kendall Law Group has substantial experience representing investors in mergers and acquisitions nationwide. Lawyers at the firm include a former United States Attorney, federal judicial law clerk, a former state and federal judge, in addition to experienced securities lawyers.

Grafico Azioni Quadramed Corp (MM) (NASDAQ:QDHC)
Storico
Da Mag 2024 a Giu 2024 Clicca qui per i Grafici di Quadramed Corp (MM)
Grafico Azioni Quadramed Corp (MM) (NASDAQ:QDHC)
Storico
Da Giu 2023 a Giu 2024 Clicca qui per i Grafici di Quadramed Corp (MM)